Oncology Archives - Page 13 of 22

The TARGET UK Study: real-world evidence of molecular response to tyrosine kinase inhibitors supports European LeukemiaNet 2013 recommendations for the management of Chronic Myeloid Leukaemia

Authors: D Milojkovic, R Clark, J Byrne, B Huntly, M Raghavan, F Wandroo, S Ali, B Austen, J Ryan, K Friedrich, N C P Cross, A Mead Published: Blood, 2017 View publication...

The incidence, diagnostic pathway and management of pulmonary carcinoid tumours in the UK: Results from the National Lung NET pathway (‘LEAP’) Project

Authors: W Mansoor, S Ferguson, D Talbot Published: 2018 View publication

The missing malignancies – follow-up of patients with pulmonary carcinoid tumours in the UK: Results from the National Lung NET Pathway (LEAP) Project

Authors: W Mansoor, S Ferguson, D Talbot Published: Endocrine Abstracts, 2017 View publication Introduction Close long-term follow-up of patients with pulmonary carcinoid (PC) tumours is important for detection of recurrence, which can...

Inferior Clinical Outcomes With Fixed-Duration Therapy for Transplant-Ineligible Myeloma Patients: UK Real-World Datain Comparison With the FIRST Trial (MM-020)

Authors: F Sharpley, F Djebbari, S Fourali, J Kothari, J Lynes, S McLain-Smith, K Ramasamy Published: Blood, 2017 View publication Background Continuous therapy for patients with transplant-ineligible (TNE) newly diagnosed multiple myeloma...

Age (≤75 years) and Not Choice of First-line Therapy Improves Overall Survival in Transplant Ineligible NDMM Patients: Results from a Large UK Real-World Dataset

Authors: F Djebbari, F A Sharpley, C Sweeney, S Fourali, G Vallance, A Peniket, L Ferguson, S McLain-Smith, J Kothari, K Ramasamy Published: Blood, 2017 View publication Background UK standard of care...

End of life secondary care resource use and costs in mycosis fungoides and Sézary Syndrome: An analysis of hospital episode statistics

Authors: N Muszbek, F Glen, D Heaton, L McNamara Published: Value in Health, 2020 View publication Introduction Cutaneous T-cell lymphomas (CTCL) are a rare heterogeneous sub-group of non-Hodgkin’s lymphomas with debilitating consequences....

Analysis of hospital episode statistics data to demonstrate the secondary care treatment pathway and outcomes of patients with cutaneous T-Cell lymphoma in England

Authors: N Muszbek, F Glen, D Heaton, L McNamara Published: 2020 View publication Objectives This study aimed to describe the real-world demographics, management, clinical outcomes and healthcare resource use (HCRU) and costs...

PCN298 DEVELOPMENT OF A NOVEL CONCEPTUAL MODEL TO DESCRIBE THE PATIENT REPORTED IMPACT OF LIVING WITH NON-SMALL CELL LUNG CANCER

Authors: J Bernarde, HK Yang, G Barnes, C Bottomley, B Tang Published: 2020 View publication Objectives Quality of Life (QoL) is an important outcome to determine the impact of treatments on patients’...

Real‐world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: The UK TARGET CML study

Authors: D Milojkovic, Huntly, S Marshall, M F McMullin, P Neelakantan, M Raghavan, M Sivakumaran, J Tighe, F Wandroo, F Willis, F Glen, L Fildes, S J Collington, J Ryan, R E...

News